Table 2.
Relationship between expression of Bcl-2 and clinicopathological parameters in gastric cancer
| Variable | Cases | Positive (%) | Negative (%) | χ2 | P value |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 28 | 20 (71%) | 8 (29%) | 0.006 | 0.940 |
| Female | 12 | 8 (67%) | 4 (33%) | ||
| Age | |||||
| ≤60 | 18 | 12 (67%) | 6 (33%) | 0.173 | 0.677 |
| >60 | 22 | 16 (73%) | 6 (27%) | ||
| Differentiation | |||||
| High | 12 | 10 (83%) | 2 (17%) | ||
| Median | 14 | 10 (71%) | 4 (29%) | ||
| Low | 14 | 8 (57%) | 6 (43%) | 1.033 | 0.309 |
| Stage | |||||
| I/II | 12 | 8 (67%) | 4 (33%) | 0.006 | 0.940 |
| III/IV | 28 | 20 (71%) | 8 (29%) | ||
| LN metastasis | |||||
| Positive | 26 | 16 (62%) | 10 (62%) | 1.512 | 0.219 |
| Negative | 14 | 12 (86%) | 2 (14%) |